Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans

被引:40
作者
Feinle, C
Grundy, D
Otto, B
Fried, M
机构
[1] Univ Zurich Hosp, Div Gastroenterol, CH-8091 Zurich, Switzerland
[2] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
[3] Univ Munich, Klinikum Innenstadt, Med Klin, D-80366 Munich, Germany
关键词
cholecystokinin; gastric distension; nausea; vasopressin; dose-response relationship;
D O I
10.1152/ajpregu.2000.278.5.R1217
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Duodenal lipid causes gastric relaxation, CCK secretion, and nausea. Vasopressin has been implicated in motion sickness-related nausea. We hypothesized that increasing doses of lipid enhance gastric relaxation and CCK-vasopressin secretion, resulting in a dose-related exacerbation of nausea. Nine healthy subjects received isotonic saline or lipid (1, 2, or 3 kcal/min, L1, L2, L3) duodenally. Changes in gastric volume, sensations, and plasma hormone levels were assessed during infusions and isobaric gastric distensions. Lipid infusions increased gastric volume, plasma CCK (but not vasopressin) levels, and gastric compliance during distensions, compared with saline. Plasma CCK levels were related to the dose of lipid administered [CCK levels at 30 min (pmol/l), saline: 1.1 +/- 0.2, L1: 1.8 +/- 0.2, L2: 3.0 +/- 0.2, L3: 4.3 +/- 0.6]. During distensions, nausea increased in intensity with increasing doses of lipid [score (where 0 is no sensation and 100 is strongest sensation), saline: 7 +/- 4, L1: 19 +/- 7, L2: 44 +/- 7, L3: 66 +/- 8]; however, no further rise in plasma CCK occurred. Because neither lipid nor distension alone induced significant nausea, we conclude that the interaction between these stimuli together with a modulation by CCK is responsible for the effects observed. Vasopressin is not involved in lipid- and distension-induced nausea.
引用
收藏
页码:R1217 / R1223
页数:7
相关论文
共 24 条
[1]
DISTRIBUTION AND RELEASE OF HUMAN PANCREATIC POLYPEPTIDE [J].
ADRIAN, TE ;
BLOOM, SR ;
BRYANT, MG ;
POLAK, JM ;
HEITZ, P ;
BARNES, AJ .
GUT, 1976, 17 (12) :940-944
[2]
HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY [J].
ADRIAN, TE ;
FERRI, GL ;
BACARESEHAMILTON, AJ ;
FUESSL, HS ;
POLAK, JM ;
BLOOM, SR .
GASTROENTEROLOGY, 1985, 89 (05) :1070-1077
[3]
INVIVO NUCLEAR-MAGNETIC-RESONANCE IMAGING AND SPECTROSCOPY OF AQUATIC ORGANISMS [J].
BLACKBAND, SJ ;
STOSKOPF, MK .
MAGNETIC RESONANCE IMAGING, 1990, 8 (02) :191-198
[4]
BLACKBURN AM, 1982, RADIOIMMUNOASSAY GUT, P146
[5]
Gastric accommodation and perception: Control via nutrient-specific intestinal afferents [J].
Carrasco, M ;
Azpiroz, F ;
Malagelada, JR .
GASTROENTEROLOGY, 1998, 114 (04) :A731-A731
[6]
DEPONTI F, 1990, J GASTROINTEST MOTIL, V2, P1
[7]
Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension [J].
Feinle, C ;
Grundy, D ;
Read, NW .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (03) :G721-G726
[8]
VASOPRESSIN AND OXYTOCIN RESPONSES TO ILLUSORY SELF-MOTION AND NAUSEA IN MAN [J].
KOCH, KL ;
SUMMYLONG, J ;
BINGAMAN, S ;
SPERRY, N ;
STERN, RM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (05) :1269-1275
[9]
EFFECT OF A LOW-DOSE OF INTRADUODENAL FAT ON SATIETY IN HUMANS - STUDIES USING THE TYPE-A CHOLECYSTOKININ RECEPTOR ANTAGONIST LOXIGLUMIDE [J].
LIEVERSE, RJ ;
JANSEN, JBMJ ;
MASCLEE, AAM ;
ROVATI, LC ;
LAMERS, CBHW .
GUT, 1994, 35 (04) :501-505
[10]
NEUROHYPOPHYSEAL SECRETION IN RESPONSE TO CHOLECYSTOKININ BUT NOT MEAL-INDUCED GASTRIC DISTENSION IN HUMANS [J].
MIASKIEWICZ, SL ;
STRICKER, EM ;
VERBALIS, JG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (04) :837-843